Drug Shortage Report for DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
Report ID | 94226 |
Drug Identification Number | 01977547 |
Brand name | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP |
Common or Proper name | DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
Strength(s) | 4MG |
Dosage form(s) | LIQUID |
Route of administration | INTRA-ARTICULAR INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1 VIAL |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-09-18 |
Estimated end date | 2019-10-01 |
Actual end date | 2019-09-30 |
Shortage status | Resolved |
Updated date | 2019-10-01 |
Company comments | Stock is available at McKesson. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-10-01 | English | Compare |
v5 | 2019-09-30 | French | Compare |
v4 | 2019-09-30 | English | Compare |
v3 | 2019-09-19 | English | Compare |
v2 | 2019-09-18 | French | Compare |
v1 | 2019-09-18 | English | Compare |
Showing 1 to 6 of 6